Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.
Ujihara N, Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Kasahara T, Tomonaga O, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Ujihara N, et al. Among authors: iwamoto y. Diabetol Int. 2017 Jul 28;9(1):56-65. doi: 10.1007/s13340-017-0330-2. eCollection 2018 Feb. Diabetol Int. 2017. PMID: 30603350 Free PMC article.
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study.
Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Ujihara N, Kasahara T, Tomonaga O, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Sakura H, et al. Among authors: iwamoto y. BMC Endocr Disord. 2016 Dec 1;16(1):70. doi: 10.1186/s12902-016-0149-z. BMC Endocr Disord. 2016. PMID: 27905912 Free PMC article.
Renal Function During an Open-Label Prospective Observational Trial of Sitagliptin in Patients With Diabetes: A Sub-Analysis of the JAMP Study.
Tomonaga O, Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Ujihara N, Kasahara T, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Tomonaga O, et al. Among authors: iwamoto y. J Clin Med Res. 2018 Jan;10(1):32-40. doi: 10.14740/jocmr3225w. Epub 2017 Dec 1. J Clin Med Res. 2018. PMID: 29238432 Free PMC article.
Analysis of the effect of seasonal administration on the efficacy of sitagliptin: Subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes Study.
Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Ujihara N, Kasahara T, Tomonaga O, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Sakura H, et al. Among authors: iwamoto y. J Diabetes Investig. 2018 Sep;9(5):1159-1166. doi: 10.1111/jdi.12817. Epub 2018 Mar 25. J Diabetes Investig. 2018. PMID: 29427314 Free PMC article.
Erratum to: Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.
Ujihara N, Sakura H, Hashimoto N, Sasamoto K, Ohashi H, Hasumi S, Kasahara T, Tomonaga O, Nunome H, Honda M, Iwamoto Y; JAMP Study Investigators. Ujihara N, et al. Among authors: iwamoto y. Diabetol Int. 2017 Oct 14;9(1):66-67. doi: 10.1007/s13340-017-0338-7. eCollection 2018 Feb. Diabetol Int. 2017. PMID: 30605174 Free PMC article.
[Glycoprotein PC-1].
Teno S, Iwamoto Y. Teno S, et al. Among authors: iwamoto y. Nihon Rinsho. 2002 Jul;60 Suppl 7:621-5. Nihon Rinsho. 2002. PMID: 12238108 Review. Japanese. No abstract available.
[Membrane glycoprotein PC-1 and insulin resistance].
Teno S, Iwamoto Y. Teno S, et al. Among authors: iwamoto y. Nihon Rinsho. 1997 Nov;55 Suppl:812-6. Nihon Rinsho. 1997. PMID: 9434569 Review. Japanese. No abstract available.
2,127 results